Background
==========

Efforts have been made to develop new methods to improve the diagnosis of intraductal lesions and their surgical removal. We evaluated the therapeutic value of a new scarless operation, endoscopic papillomectomy, (EP) in patients with pathologic nipple discharge (PND).

Methods
=======

Breast ductoscopy was performed on 213 female patients with PND. These patients underwent a variety of appropriate ductoscopy-assisted (DA) endosurgical interventions, combined with cytologic examinations. Success was determined by recurrence of PND and by standard radiological examinations.

Results
=======

Ductoscopy was successfully performed in 178 patients. Of these 178 patients, 34 had solitary papillomas (SP), 8 had multiple papillomas (MP), 19 had intraductal debris and 5 had ductal epithelial surface abnormality with positive cytology. Of the 34 polypoid lesions (cytology negative), 22 were excised endoscopically (endoscopic papillomectomy). Patients with MP underwent DA-microdochectomy. These 42 patients (34 with SP, and 8 with MP) had histopathology results consistent with intraductal papillomas or papillomatosis. Five patients with positive cytology underwent DA-terminal ductal lobular unit excision after their histopathology reports showed had DCIS. Except in one patient, all discharges disappeared. After a mean ± SD follow up time of 14.4 ± 5.2 months (range, 1--27 months), there were no recurrences of nipple discharge and no radiological results suggestive of malignancy. Thus, the therapeutic efficacy of EP in our study was 95.4% (21/22).

Conclusion
==========

Ductoscopy is not only a diagnostic procedure, but is also therapeutic for breast papillomas. EP is a new scarless treatment option for patients with PND (1,2). With technical improvements in ductoscopy and endoscopic sampling instruments, a greater degree of therapeutic efficacy will be achieved.
